MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
PAVMZ Pavmed Inc C/Wts 30/04/2024(To Pur Com) Class Z
- 0.0101
- -0.0049-32.67%
Close Dec 20 16:00 ET
134.77KMarket Cap0.00P/E (TTM)
0.0195High0.0100Low16.38KVolume0.0150Open0.0150Pre Close210.00Turnover0.12%Turnover Ratio0.00P/E (Static)13.34MShares0.180052wk High0.00P/B134.77KFloat Cap0.010052wk Low--Dividend TTM13.34MShs Float8.0700Historical High--Div YieldTTM63.33%Amplitude0.0012Historical Low0.0120Avg Price1Lot Size
About Pavmed Inc C/Wts 30/04/2024(To Pur Com) Class Z Company
PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices, Diagnostics, Digital Health, and Emerging Innovations. The company's products include cell collection devices, esophageal DNA tests, carpal tunnel release, implantable intraosseous vascular access devices, and antimicrobial resorbable ear tubes. PAVmed was founded on June 26, 2014 and is headquartered in New York, NY.
Company Profile
SymbolPAVMZ
Company NamePavmed Inc C/Wts 30/04/2024(To Pur Com) Class Z
Founded2014
CEODr. Lishan Aklog, M.D.
MarketNASDAQ
Employees107
Fiscal Year Ends12-31
Address360 Madison Avenue,25th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10017
Phone1-212-949-4319
Websitehttp://www.pavmed.com
Company Executives
- Name
- Position
- Salary
- Dr. Lishan Aklog, M.D.
- Chairman of the Board and Chief Executive Officer of the Company and Lucid
- 953.20K
- Dennis M. McGrath, C.P.A.
- Chief Accounting Officer, President and Chief Financial Officer of the Company and Lucid
- 673.50K
- Shaun M. O'Neil
- Executive Vice President and Chief Operating Officer
- 498.00K
- Michael J. Glennon
- Vice Chairman of the Board
- 228.90K
- Dr. Sundeep Agrawal, M.D.
- Director
- --
- Timothy E. Baxter
- Independent Director
- 238.90K
- Debra J. White
- Independent Director
- 248.90K
- Ronald M. Sparks, Jr
- Lead Independent Director
- 251.90K
- Michael Adam Gordon
- General Counsel and Secretary
- 710.50K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.